Current concepts of tocilizumab efficacy in active moderate-to-severe corticosteroid-resistant cases of Graves' orbitopathy. [PDF]
Boutzios G +4 more
europepmc +1 more source
Clinical Impact of Radiotherapy in Steroid-Refractory Graves' Orbitopathy. [PDF]
Escobar Peralta E +3 more
europepmc +1 more source
Effects of pulse glucocorticoid treatment on retinal blood flow in patients with active Graves' orbitopathy. [PDF]
Mohammadi H, Güneş İB, Arı Ş.
europepmc +1 more source
A randomized controlled trial on the effect of hydroxychloroquine in mild Graves' orbitopathy (GO-HCQ): study protocol. [PDF]
Lin CH +9 more
europepmc +1 more source
Role of the suppressor of cytokine signaling-3 in the pathogenesis of Graves' orbitopathy. [PDF]
Kim W +7 more
europepmc +1 more source
MMP14 as a central mediator of TGF-β1-induced extracellular matrix remodeling in graves' orbitopathy. [PDF]
Wang X +6 more
europepmc +1 more source
Statin Use and the Risk of Developing Graves' Orbitopathy in Patients With Graves' Disease: A Systematic Review and Meta-Analysis With Regional and Gender-Stratified Analyses. [PDF]
Kermaj M +4 more
europepmc +1 more source
Tryptophan metabolites exert potential therapeutic activity in graves' orbitopathy by ameliorating orbital fibroblasts inflammation and proliferation. [PDF]
Yang W +7 more
europepmc +1 more source
Novel immunoinflammatory blood markers in Graves' orbitopathy: insights into activity and severity. [PDF]
Abounoori M +5 more
europepmc +1 more source
Unilateral Graves' Orbitopathy in a Patient with Marine-Lenhart Syndrome: A case report. [PDF]
Alfutaisi A +6 more
europepmc +1 more source

